This season is keeping the curveballs coming as we try to get a read on the year's trends! But as we noted last week, we are ...

Detailed price information for Allogene Therapeutics Inc (ALLO-Q) from The Globe and Mail including charting and trades.

Absolute Difference in the Cema-Cel Arm Over the Observation Arm Exceeded Clinically Meaningful Benchmark Based on Literature of 25-30%MRD ...

For the second time in a span of four months, Insmed’s Brinsupri has come up short in a mid-stage trial designed to expand ...

Study Did Not Meet Primary or Secondary Efficacy Endpoints; Insmed Will Discontinue HS Program- -Safety Was Consistent with Previous Studies and No New Safety Signals ...

After a Phase 2 flop, Brinsupri exits the race to market for the chronic skin disease hidradenitis suppurativa, but other ...

Insmed Incorporated INSM on Tuesday shared the Phase 2b CEDAR study results for brensocatib. The study did not meet its ...

Experiencing itchy nipples? Learn the common causes, from dry skin and allergies to hormonal changes, and find out when this ...